WEGO
Shandong Weigao Group Medical Polymer Products Co. and its subsidiaries are principally engaged in the research and development
Shandong Weigao Group Medical Polymer Products Co. and its subsidiaries are principally engaged in the research and development, manufacture and sale of disposable medical devices. We provide different kinds of products, including: i) consumables (infusion sets, syringes, medical needle products, blood bags, pre-filled syringes, blood collection products and other consumables used); ii) bone materials and iii) blood purification consumables and equipment. The Company is the industrialization base of the achievements of the National High Technology Research and Development (863) Program of China, a national high-tech enterprise and a national enterprise technology center. The main production base of the Group is located in Weihai City, Shandong Province, the PRC.
Medtronic's world's first self expanding pulmonary valve was first-class recalled
EqualOcean Sector Quarterly Report - Healthcare Sectors
To help worldwide investors keep track of what is happening in each industry or sector and the related hot spots, we launched the EqualOcean Sector Quarterly Report series, which gathers notable information and statistics in each quarter.
Apr 07, 2022 01:44 PM
Inactivated vaccine against novel coronavirus of Chinese medicine Zhongsheng Omicron mutant approved for clinical use
The new crown inactivated vaccine of Sinopharm Zhongsheng Omicron mutant was approved clinically.
Research
Technology, Healthcare, Consumer StaplesWIA2020 | Rising Tech Stars 2020: Global & China's 100
Yanye said that its Xinguan oral drug s-217622 can quickly eliminate the virus
Bojian abandons Alzheimer's disease drug aduhelm and goes public in the EU
Upside foods, a cell meat enterprise, received US $400 million in financing, the highest single transaction in the industry
Lingfu biology, an experimental animal research service provider, completed a pre-A round of financing of more than 200 million yuan
Cell Image Analyzer Frim ALIT Raises over Hundreds of Mns of CNY in Series A Round
Founded in 2005, ALIT has been committed to providing advanced biological lab equipment, technology and services. The high-throughput cell analyzer platform, Castor, independently developed by the company, will be introduced to the market.
May 13, 2022 06:24 PM
Runda Medical‘s Stock Price Dips Due to False Positive Incidents
Founded in 1999, Shanghai Runda Medical provides integrated medical laboratory service by offering a full range of IVD products. Headquartered in Shanghai, the company is one of the providers of antigen tests during the Shanghai lockdown 2022. Runda is listed on the Shanghai Stock Exchange market since 2015.
May 12, 2022 12:27 PM
Hefei Tiangang immunopharmaceutical Co., Ltd., a tumor immunotherapy enterprise, completed a round of pre-A financing of hundreds of millions of yuan
Ping An Health's 2021 annual report was released, with a revenue of 7.3 billion yuan, a year-on-year increase of 8%
Moting medical obtained tens of millions of yuan a + round financing from Baidu venture capital to accelerate the expansion of ophthalmic medical device product line
Endoscope Developer Microlite Secures Tens of Mns of CNY in Angel Round
The funds will be used for the research and development of disposable endoscopes and other products, the construction of GMP (good manufacturing practice) workshops and the registration and certification of products.
May 11, 2022 11:46 PM
"Tiandu technology" won tens of millions of yuan of seed round financing, and AI computing enabled the innovative drug industry
CPPCC National Committee member Ma Xiuzhen: improve the level of grass-roots medical care through digital technology and intelligent medical care
Ruiyuan Zhao Feng position announced in the second quarter, Xiaomi group is still the largest position stocks